Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
This webinar is no longer available.
About This Webinar

In this oncology-focused webinar, Ergomed Vice President of Therapeutic Strategy for Oncology, Debra Kientop, will share with our listeners some valuable insights on how to incorporate AI and technology into oncology clinical development, focusing on how to identify the right partners and considerations that go beyond the technology.

Agenda
  • Overview of how AI and Technology can support oncology clinical development
  • When to consider hybrid and decentralized trials
  • How to navigate the crowded field of partners/vendors
  • Considerations beyond the technology
  • Q&A with our expert
Language: English
Who can attend? Anyone with the event link can attend
Featured Presenters
Webinar hosting presenter
Vice President, Therapeutic Strategy, Oncology for Ergomed
Deb is an experienced, strategic leader in oncology clinical development across Pharma, Biotech, and CRO industries. She holds an undergraduate degree in Pharmacology from the University of Wisconsin, and an MBA from the University of Wisconsin-Oshkosh. She has focus on patient-centricity and incorporating innovative solutions into clinical delivery. centricity and incorporating innovative solutions into clinical delivery.
Webinar hosting presenter
About Ergomed, plc
Founded in 1997, Ergomed plc is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed plc has provided and managed clinical development, trial management, pharmacovigilance, and medical information services for over 300 clients: these range from pharmaceutical and generics organizations to small and mid-sized drug development companies. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and Ergomed Clinical Research, a complete, global Phase I-IV clinical development and trial management services with a strong heritage in the development of drugs in rare diseases and oncology.
Hosted By
BioAlliance Video Network webinar platform hosts Navigating the Path Towards Decentralized Trials in Oncology - From Technology to AI
BioAlliance Video Network's Webinars and Video Conferences